Development of advanced three-dimensional tumour models for anti-cancer drug testing
Animal testing is still the common method to test the efficacy of new drugs, but tissue engineered in vitro models are becoming more acceptable for replacing and reducing animal testing in anti-cancer drug screening by developing <em>in vitro</em> three-dimensional (3D) tumour models for...
Autor principal: | Wan, X |
---|---|
Altres autors: | Cui, Z |
Format: | Thesis |
Idioma: | English |
Publicat: |
2014
|
Matèries: |
Ítems similars
-
Targeting cell adhesion as a method of sensitising metastatic tumour cells to TRAIL-induced apoptosis
per: Phipps, L
Publicat: (2011) -
Heterogeneity of tumour response to hypoxia: carbonic anhydrase IX induction defines a subpopulation of hypoxic cells with stem cell properties and drug resistance
per: Ledaki, I
Publicat: (2013) -
Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF
per: Knowles, H, et al.
Publicat: (2008) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
per: Mallett, S, et al.
Publicat: (2010) -
Functional analysis of cancer/testis antigens in human cancer
per: Pagotto, A
Publicat: (2013)